A noninvasive clinicopathologic and gene expression profiling (CP-GEP)–based tool, the Merlin assay, shows promise for ...
NIH cuts target $1.6 billion RECOVER initiative to study and improve treatment of long COVID, putting further research gains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback